Biomarkers in CSF | IBB-Neurobiobank

NRC-ddCJD Consortium

From January 1st 2024, Labo Neurology - Neurobiobank Instituut Born-Bunge (IBB) of the University of Antwerp and Labo Clinical Biology of the University Hospital Antwerp were recognised as a National Reference Center rare disease [NRC] consortium for diagnosing Creutzfeldt-Jakob disease (ddCJD).

see lab guide UZA 14-3-3, see lab guide UZA prion protein

over het nieuwe NRC-ddCJD Consortium - nl - v 20240610 (pdf - 600kb)
concernant le nouveau NRC-ddCJD Consortium -fr - v 20240610 (pdf - 600kb)

Sending a CSF sample for analysis

Lumbar puncture
Collection
Storage / Transport

Request forms - add to analysis request

Biomarkers in CSF - en - v 20240606 (pdf - 420kb) - (save and open in acrobat reader for full functionality)
Biomarkers in CSF - nl - v 20240606 (pdf - 420kb)
Biomarkers in CSF - fr - v 20240606 (pdf - 420kb)

Guidelines collection and sending CSF - en - v 20240308 (pdf - 317kb)
Diagnostic criteria for surveillance of sporadic CJD - en - v 201701 (pdf - 118kb)
CSF Biomarkers in Alzheimer’s Disease (AD), a descriptive classification scheme (A/T/N) - en - v 20240926 (pdf - 220kb)

Informed Consent - Prospective sampling and storage - en - v 202103 (pdf - 1006kb)
Informed Consent - Prospectieve staalname en bewaren - nl - v 202103 (pdf - 1029kb)
Informed Consent - Echantillonnage prospectif et conservation - fr - v 202103 (pdf - 1029kb)